• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ANIMAS LLC ONETOUCHPING GLUCOSEMGMTSYSTEM; INSULIN INFUSION PUMP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ANIMAS LLC ONETOUCHPING GLUCOSEMGMTSYSTEM; INSULIN INFUSION PUMP Back to Search Results
Medical Device Problem Code Inaccurate Delivery (2339)
Health Effect - Clinical Codes Headache (1880); Hypoglycemia (1912); Ambulation or Postural Difficulties (2544)
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The device has not been returned to animas for evaluation.If the device is returned, an evaluation shall be completed and a supplemental report will be filed.No conclusions can be made at this time.
 
Event or Problem Description
The reporter contacted animas on (b)(6) 2018 alleging the patient experienced hypoglycemia while on insulin pump therapy evidenced by blood glucose measuring 40 mg/dl accompanied by unsteadiness when standing and walking and severe headache.The patient reportedly did not receive any treatment above or beyond the usual routine of diabetes care and management.The reporter did not provide any information regarding treatment of the hypoglycemia.The reporter alleged the pump was delivering more insulin that it was programmed to deliver to the patient.The reporter did not complete troubleshooting of the pump with animas customer support.This complaint is being reported because the patient reportedly experienced serious injury while on insulin pump therapy associated with an alleged inaccurate insulin delivery issue.
 
Additional Manufacturer Narrative
Device evaluation: the device has been returned and evaluated by product analysis on 28 -jan-2019 with the following findings:.During investigation, the black box and alarm history showed no evidence of insulin remaining issues.The pump total daily dose (tdd) history confirmed the pump was delivering the programmed basal rate.The pump passed all required testing for delivery accuracy and insulin remaining.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ONETOUCHPING GLUCOSEMGMTSYSTEM
Common Device Name
INSULIN INFUSION PUMP
Manufacturer (Section D)
ANIMAS LLC
965 chesterbrook blvd
wayne PA 19087
MDR Report Key8037607
Report Number2531779-2018-19110
Device Sequence Number1463762
Product Code LZG
UDI-Device Identifier10840406101010
UDI-Public10840406101010
Combination Product (Y/N)Y
Initial Reporter StateCO
Initial Reporter CountryUS
PMA/510(K) Number
K080639
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source consumer
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date (Section B) 10/23/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Was Device Available for Evaluation? No
Was the Report Sent to FDA? Yes
Device Age8 MO
Initial Date Received by Manufacturer 10/23/2018
Supplement Date Received by Manufacturer10/23/2018
Initial Report FDA Received Date11/05/2018
Supplement Report FDA Received Date01/31/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Life Threatening;
Patient Age12 YR
-
-